Growth kinetics of SARS-coronavirus in Vero E6 cells

Vero E6 cells are commonly used for in vitro studies of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) and for antiviral evaluation purposes. A better understanding of the SARS-CoV growth kinetics in Vero E6 cells is crucial to help elucidate the mechanism of antiviral activity of selective antiviral agents. In this study, the growth kinetics of SARS-CoV in Vero E6 cells were studied by quantitation of intra- and extracellular viral RNA load as well as extracellular virus yield at different time points post-infection. At 12h post-infection, the intracellular viral RNA load was 3x10(2)-fold higher than at the time of infection, and the extracellular viral RNA load was increased with a factor of 2 x 10(3). Intracellular viral RNA levels started to rise at 6h post-infection. One hour later (at 7h post-infection), the levels of extracellular SARS-CoV RNA also began to rise. This was corroborated by the fact that infectious progeny SARS-CoV also first appeared in the supernatant between 6 and 7h post-infection. At 12h post-infection, SARS-CoV reached titers in the supernatant of 5.2 x 10(3) CCID(50)/ml.     

影响非洲绿猴肾细胞脂质体转染效率的因素

已有实验表明,细胞转染效率可能决定于ＤＮＡ－脂质体复合物的形成以及所转染的细胞种类。利用脂质体ＬｉｐｏｆｅｃｔＡＭＩＮＥ,研究了影响Ｖｅｒｏ细胞转染效率的参数如ＤＮＡ和脂质体的用量,转染的细胞数量以及细胞暴露于ＤＮＡ－脂质体复合物的时间长度。通过检测报告基因β－半乳糖苷酶（β－ｇａｌ）的表达,发现最高转染率只在一较窄范围内获得。β－ｇａｌ的表达随脂质体量增加而显著增加。在标准转染条件下,增加ＤＮＡ用量和延长细胞暴露时间反而使转染效率下降。转染细胞数量为４×１０４细胞／２４孔时,细胞转染效率最高。     

狂犬病毒CTN—1株在Vero细胞上的适应传代研究

本文报导了用我国狂犬病毒固定毒人二倍体细胞适应株（ＣＴＮ－１）进行Ｖｅｒｏ细胞适应传代研究。通过连续传代培养,滴度可达８．０１ｏｇＬＤ５０／ｍｌ,达到了ＷＨＯ规定的不需浓缩的标准。病毒用０．０１ＭＯＩ感染细胞其产量与１Ｍｏｌ感染量相仿。病毒增殖高峰在４－５天,维持达１５天无明显下降,且可连续收获４－５次。因此,该毒种符合ＷＨＯ提出的疫苗生产毒种要求,可用于狂犬病疫苗生产。     

Patterns of integration of exogenous DNA sequences transfected into mammalian cells of primate and rodent origin

We studied the cotransfer and cointegration of several genes transfected into four cell lines of primate origin. Mouse thymidine-kinase-negative LM cells, which had been extensively studied previously, were used as a reference. We found that in monkey kidney Vero cells, on average between 3.5 and 6.0 kb of plasmid sequences was integrated per clone, while in the murine LM cell Une, 9–186 kb of exogenous DNA was integrated per clone. Transformed Vero clones which had integrated more than 6 kb of DNA did not integrate larger DNA fragments in a second transformation assay than had the parental Vero cells. We found that the efficiency of gene cointegration is similar in Vero, HeLa and GM4312A cells, the latter being deficient in the repair of UV-induced damage. The human hepatocarcinoma Hep G2 cells integrated on the average 2 kb more exogenous DNA than the three other primate cell Unes, which resulted in a 4–5 times higher efficiency of gene cointegration. Plasmid penetration and persistence in a free state between 24 h and two weeks after transfection was similar in Vero and LM cells. No major post-integration DNA rearrangement could be demonstrated after the isolation of Vero clones. These observations correlate the low efficiency of gene cointegration in some primate cell lines with a genomic recombination step or with rearrangements taking place during early cell divisions following integration     

Effect of nicking on Shiga-like toxin I of enterohaemorrhagic Escherichia coli

Abstract The Shiga-like toxin I (SLT-I), which had an unnicked A subunit, was purified from Escherichia coli O157: H7. After incubation of the unnicked SLT-I with trypsin, the A subunit of the toxin was nicked and converted to A₁ and A₂ peptides, which were linked by the disulfide bond. The effects of nicking of SLT-I on its heat stability and cytotoxic activity against Vero cells were examined. The trypsin treatment of SLT-I neither reduced nor increased the ability of cytotoxic activity or the heat stability of the toxin. The time course of binding of the toxin to Vero cells also was not affected by nicking of the toxin. These results indicate the absence of a difference in biological or physical properties of SLTs between nicked and unnicked conditions.     

人用精制Vero细胞狂犬病疫苗纯化方法选择

人用精制Ｖｅｒｏ细胞狂犬病疫苗为一种安全、有效的新型疫苗,我们在研制该种疫苗时首先比较了密度梯度离心法和凝胶过滤柱层析法,并发现后者最佳。我们选择了以Ｓｅｐｈａｒｏｓｅ ４ＦＦ为介质的凝胶过滤柱层析的工艺,并对该方法的上样量、流速等指标进行了选择,确定了最佳方法,并在研制中使纯化疫苗的杂蛋白去除率达到９９．８％以上,为大规模生产提供了工艺方法。     

应用动力学方法在线检测Vero细胞培养过程中的摄氧率

流加和灌注培养已被广泛应用于动物细胞培养 ,以获得高活性、高密度的细胞和高的产物得率。在这些培养过程中 ,一般通过离线检测关键参数 (如细胞密度、营养和代谢产物的浓度 )来人为调整灌注速率和补料策略 ,但是 ,当细胞密度较高时 ,由于细胞代谢旺盛使得培养的微环境变化很快 ,这就需要更加频繁快速地调整操作条件 ,从而导致因频繁取样和离线分析所带来的污染危险及大量人力、物力的浪费。这在大规模细胞培养过程中是不可取的。因此 ,要建立大规模、高效动物细胞培养过程 ,有必要研究和探索在线检测技术 ,以实时掌握细胞培养过程所处的状…     

Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA)

Occurrence of infections due to the drug resistant Staphylococcus aureus is on rise necessitating the need for rapid development of new antibacterial agents. In our present work, a series of new 3-phenylquinazolin-4(3H)-one derivatives were designed, synthesized and evaluated for their antibacterial activity against ESKAP (E. coli, S. aureus, K. pneumoniae, A. baumannii, P. aeroginosa) pathogen panel and pathogenic mycobacterial strains. The study revealed that compounds 4a, 4c, 4e, 4f, 4g, 4i, 4o and 4p exhibited selective and potent inhibitory activity against Staphylococcus aureus with MIC values in the range of 0.125–8 µg/mL. Further, the compounds 4c, 4e and 4g were found to be non toxic to Vero cells (CC₅₀ = >10–>100 µg/mL) and exhibited favourable selectivity index (SI = 40–>200). The compounds 4c, 4e and 4g also showed potent inhibitory activity against various MDR-S. aureus including VRSA. The promising results obtained indicated the potential use of the above series of compounds as promising antibacterial agents for the treatment of multidrug resistant Staphylococcus aureus infections.     

VERO细胞生物反应器放大培养初探

目的:研究用生物反应器放大进行Vero细胞微载体培养,实现生物反应器之间Veto细胞放大培养.方法:5L微载体生物反应器以10g/L微载体浓度培养Vero细胞,96h时经漂洗、消化、接种于30L微载体生物反应器,实现放大后的30L微载体生物反应器细胞怏速增殖,期间对不同时期的微载体细胞进行细胞计数、细胞代谢分析和形态观察.结果:5L生物反应器细胞经过96h灌注培养,平均细胞密度达到7.81×10~6cells/mL.5L微载体细胞放大到30L微载体生物反应器,平均细胞收获率为32.3%;放大到30L生物反应器后经过144h培养,细胞密度达到9.19×10~6cells/mL;放大后的细胞代谢途径依然以葡萄糖氧化代谢乳酸为主.结论:生物反应器由5L到30L进行Veto细胞放大培养是可行的.